Lepu Medical (300562.SZ) announced its semi-annual report with a revenue of CNY 0.499 billion, a year-on-year increase of 29.63%, a net income of CNY 34.8497 million, a year-on-year increase of 303.72%, a non-net profit of CNY 32.38 million, a year-on-year increase of 313.83%, and a basic earnings per share of CNY 0.1607. A cash dividend of CNY 1.3 will be distributed to all shareholders for every 10 shares.
Based on the company's strong medical-grade intelligent health device manufacturing capabilities, digital software research and development advantages, and high-quality medical industry partnership resources, the company is accelerating the commercialization of digital health services and striving to create the second growth curve of enterprise development. During the reporting period, the company focused on the field of cardiovascular and cerebrovascular diseases, integrated "remote health monitoring equipment + AI software + medical services", and deeply deployed two major innovative businesses: digital blood pressure management services and remote dynamic electrocardiogram services.